Stat3 may play a crucial role in BFT-mediated IL-8 secretion, as induction of IL-8 secretion in response to ETBF treatment was diminished when CRC cell lines were treated with either a Stat3 or β-catenin antagonist. This evidence concerns the gene CXCL8 and colorectal carcinoma.